Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
about
Monoclonal antibody form and function: manufacturing the right antibodies for treating drug abuseThe central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP moduleDeletion of the Pichia pastoris KU70 homologue facilitates platform strain generation for gene expression and synthetic biologyOptimized expression of the dirigent protein AtDIR6 in Pichia pastoris and impact of glycosylation on protein structure and function.Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate.A simple Pichia pastoris fermentation and downstream processing strategy for making recombinant pandemic Swine Origin Influenza a virus Hemagglutinin protein.Genome, secretome and glucose transport highlight unique features of the protein production host Pichia pastoris.Optimized expression of a thermostable xylanase from Thermomyces lanuginosus in Pichia pastoris.Improved production of human type II procollagen in the yeast Pichia pastoris in shake flasks by a wireless-controlled fed-batch system.Scaling-up Fermentation of Pichia pastoris to demonstration-scale using new methanol-feeding strategy and increased air pressure instead of pure oxygen supplementEnhancement of thermoalkaliphilic xylanase production by Pichia pastoris through novel fed-batch strategy in high cell-density fermentation.Functional characterization of recombinant batroxobin, a snake venom thrombin-like enzyme, expressed from Pichia pastoris.Heterologous expression of membrane and soluble proteins derepresses GCN4 mRNA translation in the yeast Saccharomyces cerevisiaeMolecular cloning and heterologous expression of a true lipase in Pichia pastoris isolated via a metagenomic approach.Development and application of a suite of polysaccharide-degrading enzymes for analyzing plant cell walls.Enhanced production of recombinant secretory proteins in Pichia pastoris by optimizing Kex2 P1' site.Carboxyl-terminal truncations alter the activity of the human α-galactosidase AOverexpression of membrane proteins from higher eukaryotes in yeasts.Validation of an FBA model for Pichia pastoris in chemostat cultures.Integration and Validation of the Genome-Scale Metabolic Models of Pichia pastoris: A Comprehensive Update of Protein Glycosylation Pathways, Lipid and Energy MetabolismTransgenic plants in the biopharmaceutical market.Physiological response of Pichia pastoris GS115 to methanol-induced high level production of the Hepatitis B surface antigen: catabolic adaptation, stress responses, and autophagic processes.Design and construction of two yeast shuttle vectors containing human procollagen genes expression cassette for expression in yeast.Large-scale functional expression of WT and truncated human adenosine A2A receptor in Pichia pastoris bioreactor culturesPotential of Ophiostoma piceae sterol esterase for biotechnologically relevant hydrolysis reactions.Glycoengineering of human IgG1-Fc through combined yeast expression and in vitro chemoenzymatic glycosylation.Simple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigenCombined 13C-assisted metabolomics and metabolic flux analysis reveals the impacts of glutamate on the central metabolism of high β-galactosidase-producing Pichia pastoris.A recombinant multi-antigen vaccine formulation containing Babesia bovis merozoite surface antigens MSA-2a1, MSA-2b and MSA-2c elicits invasion-inhibitory antibodies and IFN-γ producing cellsOptimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera.Assay and heterologous expression in Pichia pastoris of plant cell wall type-II membrane anchored glycosyltransferasesApplications of recombinant Pichia pastoris in the healthcare industry.Sense and nonsense from a systems biology approach to microbial recombinant protein production.Expression of Neospora caninum NcSRS2 surface protein in Pichia pastoris and its application for serodiagnosis of Neospora infection.Chymosin and other milk coagulants: sources and biotechnological interventions.Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbes.Advances in the production of membrane proteins in Pichia pastoris.Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.Functional expression and characterisation of membrane transport proteins.Recent developments in yeast cell surface display toward extended applications in biotechnology.
P2860
Q24632128-2C94149B-83DD-443F-ADD6-7764FF4DE33BQ24646284-5B09607A-BEF2-436B-9C02-37AE4C28E877Q28727694-76816FD0-DDEC-493B-B506-60CBCE0A907FQ30155174-4A76ABC4-5598-4145-BC04-E3FA3BB793E2Q30401512-F88EBC7D-CB4A-4275-902F-6200F32DF02DQ30424895-9568642F-73E2-49BC-9A29-9BB15A613F6EQ30484154-9735811D-717A-4427-881C-1CCFC188DE3EQ33193746-E4E1D37A-7A31-4EE9-A679-35C1CD4A58FBQ33326024-0D9325EE-B82E-49EC-8FD9-DE01BDBD2889Q33467010-21E19D7E-D0F2-422F-8A57-38C33F9E1CDDQ33820281-7720808D-4E63-479A-A2D1-4203AC523492Q34336597-8BB62DF8-37F3-4F56-9E06-AD2EB6865D17Q34461681-20F6EA1E-2706-4FB6-B2B9-F286B323C8C5Q34467789-F3C6DBFD-2AD9-44D8-99E6-D50671752DCAQ34984080-64B1CE1D-5131-4D85-B1C5-6C693268CEC5Q34999563-76FD4FDA-656B-4605-ADD8-E36076949B49Q35125851-C4487206-E092-4E42-B819-F224F3296D87Q35214601-90C13E90-E216-472E-A4D1-C73610BADF37Q35533733-3D707E02-6E9A-4024-BBA9-055C591DF5B2Q35905001-DC17E29C-E032-423C-8422-2A8124F4FE65Q36066053-83DE466F-C0CB-48A9-B2AC-5E3C9769A07EQ36517517-BF9FB281-6B75-4849-9213-FBD64869E7D8Q36571358-30DCC10D-C9A0-430C-A03A-90EA7D9A0C3AQ36943625-AF691D69-1277-47DB-9B81-6371C40AFA4FQ37057147-E2CFA342-F4C7-4DE2-8758-477996CFB1E6Q37066000-FB6C0185-0142-41E6-A5EA-4CECD8ED7822Q37107055-8F0F56B1-C4EA-4EA3-8B8E-E557A519DDB7Q37389631-CB8A9C69-4134-4E9B-86D4-5AA1A94E158CQ37414586-E2EB171A-1AC2-463E-B80A-D27353006BF8Q37414819-4DD5B74D-A115-40CA-A904-65C6BD7C9AD5Q37475679-87D30D22-1ACC-43D9-B34E-C9956B41C653Q37644186-C4EF2F28-85F7-44B7-9D69-DC8D562EE3A3Q37665886-10BA2678-3F2B-438E-B23E-31E5692D1074Q37730340-A18A69EA-FB9B-4C48-ACC1-1B48A208105BQ37762812-FC2114E8-80CA-410F-A094-676FB2DC0005Q37810229-F7E35E88-B373-4870-BBC7-FD19A6019D20Q37875027-D61477F5-1D85-40F5-BB95-79869069A7A3Q37928986-18664F62-CDBD-4866-9E43-A2ECB6D6233FQ38013776-1BF4531F-8839-4181-9A79-8AA69626F2CEQ38015164-9AE6FC13-95A8-4B45-B1BE-90FD183A53AF
P2860
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
@ast
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
@en
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
@nl
type
label
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
@ast
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
@en
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
@nl
prefLabel
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
@ast
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
@en
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
@nl
P2093
P1476
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.
@en
P2093
Christine Ilgen
Geoff P Lin Cereghino
James M Cregg
Joan Lin Cereghino
P304
P356
10.1016/S0958-1669(02)00330-0
P577
2002-08-01T00:00:00Z